Alyeska Investment Group, L.P.

Q4 2017 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Brent Cunningham - Chief Compliance Officer
Location
Chicago, IL
Holdings as of
31 Dec 2017
Value $
$0
Num holdings
1
Filing time
19 Nov 2018, 14:38:16 UTC
Form type
13F-HR/A-3 - New Holdings
Description
Top holdings included . Request for Confidential Treatment (14 Feb 2018): Confidential Treatment Expired on 14 Nov 2018.
Previous filing
Q3 2017 - 14 Nov 2017
Next filing
Q1 2018 - 15 May 2018
Our algorithm has found invalid data in this filing
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 14 Feb 2018 pursuant to a request for confidential treatment and for which confidential treatment expired on 14 Nov 2018.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Brent Cunningham Chief Compliance Officer Chicago, Illinois 19 Nov 2018

Other Included Managers (2):

Num Name Location File Number
1 Alyeska Master Fund, L.P. Chicago, IL 028-13417
2 Alyeska Master Fund 2, L.P. Chicago, IL 028-16151